Hjem › Pladecellekarcinom i øsofagus
Pladecellekarcinom i øsofagus kliniske forsøg rekrutterer i USA
34 studier for Pladecellekarcinom i øsofagus rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Arlington, VA14 studier
- Nashville, TN12 studier
- Houston, TX12 studier
- Los Angeles, CA11 studier
- Baldwin Park, CA8 studier
- West Valley City, UT7 studier
- San Antonio, TX7 studier
- New York City, NY7 studier
- Santa Monica, CA6 studier
- Queens, NY6 studier
- Dallas, TX5 studier
- Orlando, FL5 studier
- Boston, MA5 studier
- Detroit, MI5 studier
- Fort Worth, TX5 studier
- Austin, TX4 studier
- St. Louis, MO4 studier
- Irvine, CA4 studier
- Atlanta, GA4 studier
- Portland, OR4 studier
- Grand Rapids, MI4 studier
- Cleveland, OH4 studier
- Pittsburgh, PA4 studier
- Chicago, IL3 studier
- Coral Springs, FL3 studier
- Rochester, MN3 studier
- Omaha, NE3 studier
- San Francisco, CA3 studier
- Las Vegas, NV3 studier
- Fullerton, CA3 studier
- Orange, CA3 studier
- Irving, TX3 studier
- New Haven, CT3 studier
- Bridgeport, CT3 studier
- Seattle, WA3 studier
- Durham, NC3 studier
- Philadelphia, PA3 studier
Efter delstat
- Arizona6 studier
- Californien24 studier
- Connecticut4 studier
- Florida11 studier
- Georgia4 studier
- Illinois5 studier
- Massachusetts5 studier
- Michigan10 studier
- Minnesota5 studier
- Missouri5 studier
- Nebraska3 studier
- Nevada3 studier
- New Jersey5 studier
- New York14 studier
- North Carolina4 studier
- Ohio8 studier
- Oregon4 studier
- Pennsylvania8 studier
- Tennessee12 studier
- Texas19 studier
- Utah7 studier
- Virginia14 studier
- Washington6 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06780111A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07405151A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT05319730Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06265285177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07189871A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07090499A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07085091A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07277413A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06047379A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07730021A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07109726A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT07217171Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06535607A Study of IDP-001 in Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07602842A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT07554521Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT06084481Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT04221893A Study of MGC026 in Participants With Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT06242470A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT06644781A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. jul. 2026 · NCT05208762A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. jul. 2026 · NCT06657144A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 7. jul. 2026 · NCT07224750Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 7. jul. 2026 · NCT07266363A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 6. jul. 2026 · NCT04389632Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.